Africa Urged to Team Up in COVID-19 Vaccine Trials
Africa has the capacity to mass-produce vaccines against COVID-19 if they become available next year but the region will need to be more involved in their search, writes Jackie Opara for SciDev.net. Matshidiso Moeti, WHO regional director for Africa, said there is already existing vaccine manufacturing capacities in countries such as Algeria, Egypt, Ethiopia, Morocco, Senegal, South Africa and Tunisia because these facilities are involved in the development of vaccines including yellow fever and Ebola. Moeti added: "It is clear that as the international community comes together to develop safe and effective vaccines and therapeutics for COVID-19, equity must be a central focus of these efforts. Too often, African countries end up at the back of the queue for new technologies including vaccines. These life-saving products must be available to everyone, not only those who can afford to pay."
Gauteng has overtaken the Western Cape as the epicentre of South Africa's COVID-19 outbreak. Further, the Gauteng Department of Health confirmed that six members of its COVID-19 ... Read more »
The South African Ox1Cov-19 Vaccine VIDA-trial developed by Wits University researchers is a first for Africa and one of 268 other candidate vaccines currently being researched and ... Read more »
The Central Bank of Nigeria said it is reviewing funding requests by local researchers to support the local development of vaccines and drugs for COVID-19. In Nigeria, the latest ... Read more »
The ministry of health has denied knowledge of plans by Oxford University researchers to test their vaccines on Kenyans because of the lower COVID-19 transmission rates in the ... Read more »
Coronavirus testing (file photo).